Sponsors

Maquet Getinge Group
Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, Getinge and Maquet. ArjoHuntleigh focuses on patient mobility and wound management solutions. Getinge provides solutions for infection control within healthcare and contamination prevention within life sciences. Maquet specializes in solutions, therapies and products for surgical intercentions, interventional cardiology and intensive care.




Partner





Exhibitors

Al Mashriq Medical Supplies(AMMS) is a 100% U.A.E. owned company dealing exclusively in medical and laboratory equipment, consumables and supplies. It represents a number of known medical equipment and consumable manufactures. The company has been progressing steadily and has made significant inroads within the medical services in the UAE. AMMS has a team of Qualified Engineers & Technicians well trained in the manufacturing facilities and giving a full Service & Technical support on all our range of Products.

OriGen Biomedical is a medical device manufacturer, based in Austin, TX with 25+ years of experience in respiratory support medical supplies.

We manufacture a full range of respiratory care products including: wire reinforced dual-lumen veno-venous ECMO catheters suited to support neonatal to adult sized patients.

We manufacture ancillary ECMO Products, including percutaneous introducer kits used in conjunction with the VV catheters or ECMO equipment.

Also available for sale outside of the USA are sterile filled perfluorcarbon lung lavage solutions that aid in the removal of foreign materials and tenacious bronchial secretions. For more information visit our website at www.origen.com


is a commercial-stage company and the recognized technology leader in minimally invasive medical devices that unite one console (XENIOS) with next-generation lung and heart therapies into a single platform for a market with revenue potential of nearly $9 billion.